| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/01/2020 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Director Stock Option (right to buy) | 7k | $12.88 | $90.2k | | 10/01/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Series C Preferred Stock | 265.2k | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Series B Preferred Stock | 1M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Series A Preferred Stock | 3.5M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Series Seed Preferred Stock | 1.6M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Common Stock | 265.2k | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Common Stock | 1M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Common Stock | 3.5M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Common Stock | 1.6M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Common Stock | 1.6M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Common Stock | 3.5M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Common Stock | 1M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Common Stock | 265.2k | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Series Seed Preferred Stock | 1.6M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Series A Preferred Stock | 3.5M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Series B Preferred Stock | 1M | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/29/2020 | PMV Pharmaceuticals, Inc. | PMVP | Conversion | Series C Preferred Stock | 265.2k | $0.00 | $0 | See footnote | 09/25/2020 |
| 09/25/2020 | PMV Pharmaceuticals, Inc. | PMVP | Purchase | Common Stock | 55.6k | $18.00 | $1000k | See footnote | 09/25/2020 |
| 09/25/2020 | PMV Pharmaceuticals, Inc. | PMVP | Purchase | Common Stock | 55k | $18.00 | $990k | See footnote | 09/25/2020 |
| 05/28/2020 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Option (Right to Buy) | 25k | $4.84 | $121k | | 05/28/2020 |
| 10/02/2019 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Director Stock Option (Right to Buy) | 7k | $11.21 | $78.5k | | 10/02/2019 |
| 05/30/2019 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Option (Right to Buy) | 15k | $4.97 | $74.6k | | 05/30/2019 |
| 10/03/2018 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Director Stock Option (Right to Buy) | 7k | $22.65 | $158.6k | | 10/03/2018 |
| 09/10/2018 | KalVista Pharmaceuticals, Inc. | KALV | Purchase | Common Stock | 58.8k | $17.00 | $1M | InterWest Partners IX, L.P. | 09/10/2018 |
| 08/07/2018 | TESARO, Inc. | TSRO | Exercise | Common Stock | 10k | $0.00 | $0 | | 08/07/2018 |
| 08/07/2018 | TESARO, Inc. | TSRO | Sale | Common Stock | 10k | $26.77 | $267.7k | | 08/07/2018 |
| 08/07/2018 | TESARO, Inc. | TSRO | Exercise | Director Nonqualified Stock Option (right to buy) | 10k | $26.36 | $263.6k | | 08/07/2018 |
| 05/31/2018 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Option (Right to Buy) | 15k | $15.80 | $237k | | 05/31/2018 |
| 09/27/2017 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Director Stock Option (Right to Buy) | 6k | $6.71 | $40.3k | | 09/27/2017 |
| 06/02/2017 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Option (Right to Buy) | 7.5k | $5.90 | $44.2k | | 06/02/2017 |
| 06/01/2017 | TESARO, Inc. | TSRO | Grant | Director Nonqualified Stock Option (right to buy) | 12k | $149.22 | $1.8M | | 06/01/2017 |
| 06/01/2017 | TESARO, Inc. | TSRO | Grant | Common Stock | 335 | $0.00 | $0 | By corporation | 06/01/2017 |
| 03/23/2017 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Director Stock Option (Right to Buy) | 12k | $7.88 | $94.6k | | 03/23/2017 |
| 06/01/2016 | TESARO, Inc. | TSRO | Grant | Director Nonqualified Stock Option (right to buy) | 12k | $47.27 | $567.2k | | 06/01/2016 |
| 05/31/2016 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Option (Right to Buy) | 7.5k | $16.59 | $124.4k | | 05/31/2016 |
|